LobbyingSumma Health lobbying by quarter
Summa Health's latest lobbying report covers Q2 2026, at $30K. The four quarters Q3 2025–Q2 2026 total $240K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Summa Health
- Latest quarter
- $30K
- Q2 2026 · 1 reports
- Last 12 months
- $240K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $34.9K | 1 |
| Q1 2023 | $12.4K | 1 |
| Q2 2023 | $42.4K | 2 |
| Q3 2023 | $64K | 2 |
| Q4 2023 | $64K | 2 |
| Q1 2024 | $64K | 2 |
| Q2 2024 | $60K | 2 |
| Q3 2024 | $60K | 2 |
| Q4 2024 | $60K | 2 |
| Q1 2025 | $90K | 2 |
| Q2 2025 | $90K | 2 |
| Q3 2025 | $90K | 2 |
| Q4 2025 | $90K | 2 |
| Q1 2026 | $30K | 2 |
| Q2 2026 | $30K | 1 |
Policy issues the reports name
- Health issues26 reports
- Medicare and Medicaid26 reports
- Budget and appropriations13 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES26 reports
- SENATE26 reports
- Centers For Medicare and Medicaid Services (CMS)3 reports
- Health Resources & Services Administration (HRSA)3 reports
- Health & Human Services, Dept of (HHS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseSumma Health | $491.6K | 14 quarters |
| Alston & Bird | $390K | 13 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Alston & Bird | $30K |
| 04/20for Q1 | Alston & Bird | $30K |
| 02/07for Q1 | In-house | Under $5,000 |
| 01/20for Q4 2025 | Alston & Bird | $30K |
| 01/11for Q4 2025 | In-house | $60K |
| 25/10/20for Q1 2025 | In-house | $60K |
| 25/10/20for Q2 2025 | In-house | $60K |
| 25/10/20for Q3 2025 | In-house | $60K |
| 25/10/20for Q3 2025 | Alston & Bird | $30K |
| 25/07/21for Q2 2025 | Alston & Bird | $30K |
| 25/07/17for Q2 2025 | In-house | $30K |
| 25/04/21for Q1 2025 | Alston & Bird | $30K |
| 25/04/15for Q1 2025 | In-house | $30K |
| 25/01/21for Q4 2024 | Alston & Bird | $30K |
| 25/01/19for Q4 2024 | In-house | $30K |
| 24/10/21for Q3 2024 | Alston & Bird | $30K |
| 24/10/15for Q3 2024 | In-house | $30K |
| 24/08/12for Q2 2024 | In-house | $30K |
| 24/07/22for Q2 2024 | Alston & Bird | $30K |
| 24/05/11for Q1 2024 | In-house | $34K |